Norethandrolone

Also known as: Ethylnortestosterone

Drug #2013

Norethandrolone is an anabolic steroid . It is given by mouth in the treatment of aplastic anaemia.

← Previous drug Next drug →

Primary Characteristics

Norethandrolone is also known as Ethylnortestosterone.

It is of Synthetic origin.

Molecular Weight: 302.45 · Non-proprietary name: Norethandrolone.

Pharmacokinetics

Elimination: it is metabolised via Hepatic.

Indications

Norethandrolone is primarily indicated in conditions like Aplastic anemia, Contraception, Endometriosis.

Contraindications

Norethandrolone is contraindicated in conditions like Breast cancer, Cardiovascular disease, Pregnancy, Breast feeding, Prostate cancer.

Dosage

Norethandrolone's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
1.1 mg/kg	1.1 mg/kg	—	PO	Daily
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Minor1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Norethandrolone in overdosage may give rise to further complications which include Hepatotoxicity , Hepatotoxicity .

The signs and symptoms that are produced after acute overdosage of Norethandrolone are Nausea, Hepatic damage, Prostate carcinoma, Jaundice , GI disturbances, Jaundice, Cardiovascular disturbances, Psychiatric disturbances, Myocardial infarction, Stroke, Muscular hypertrophy.

Norethandrolone is known to cause more or less tolerable side effects which are usually transient. These include Azoospermia, Fluid retention, GI bleeding, Headache, Impotence, Virilization, Weight gain.

Warnings / Precautions

Norethandrolone should be used with extreme care in children because of the masculinising effects and also because premature closure of the epiphyses may occur resulting in inhibited linear growth and small stature. Skeletal maturation should be monitored during therapy. Norethandrolone should be used cautiously in patients with cardiovascular disorders, renal or hepatic impairment, epilepsy, migraine, diabetes mellitus or other conditions which may be aggravated by the possible fluid retention or oedema caused. They should not be given to patients with hypercalcaemia or hypercalciuria, and should be used cautiously in conditions in which there is a risk of these developing such as skeletal metastases. Norethandroloneshould not be given during pregnancy because of the risk of virilisation of the female fetus.

Available Brands

None recorded.

Storage Conditions

Norethandrolone should be stored .

Drug Classification

1.18.11 — Anabolic drugs